Literature DB >> 27784075

Visual Contrast Sensitivity in Early-Stage Parkinson's Disease.

Wendy Ming1, Dimitrios J Palidis1, Miriam Spering2, Martin J McKeown3.   

Abstract

PURPOSE: Visual impairments are frequent in Parkinson's disease (PD) and impact normal functioning in daily activities. Visual contrast sensitivity is a powerful nonmotor sign for discriminating PD patients from controls. However, it is usually assessed with static visual stimuli. Here we examined the interaction between perception and eye movements in static and dynamic contrast sensitivity tasks in a cohort of mildly impaired, early-stage PD patients.
METHODS: Patients (n = 13) and healthy age-matched controls (n = 12) viewed stimuli of various spatial frequencies (0-8 cyc/deg) and speeds (0°/s, 10°/s, 30°/s) on a computer monitor. Detection thresholds were determined by asking participants to adjust luminance contrast until they could just barely see the stimulus. Eye position was recorded with a video-based eye tracker.
RESULTS: Patients' static contrast sensitivity was impaired in the intermediate spatial-frequency range and this impairment correlated with fixational instability. However, dynamic contrast sensitivity and patients' smooth pursuit were relatively normal. An independent component analysis revealed contrast sensitivity profiles differentiating patients and controls.
CONCLUSIONS: Our study simultaneously assesses perceptual contrast sensitivity and eye movements in PD, revealing a possible link between fixational instability and perceptual deficits. Spatiotemporal contrast sensitivity profiles may represent an easily measurable metric as a component of a broader combined biometric for nonmotor features observed in PD.

Entities:  

Mesh:

Year:  2016        PMID: 27784075     DOI: 10.1167/iovs.16-20025

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific.

Authors:  Jolande Fooken; Pooja Patel; Christina B Jones; Martin J McKeown; Miriam Spering
Journal:  J Neurosci       Date:  2021-11-30       Impact factor: 6.709

2.  Focal alteration of the intraretinal layers in neurodegenerative disorders.

Authors:  Shriya Airen; Ce Shi; Zhiping Liu; Bonnie E Levin; Joseph F Signorile; Jianhua Wang; Hong Jiang
Journal:  Ann Eye Sci       Date:  2020-03

Review 3.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

4.  Slower saccadic reading in Parkinson's disease.

Authors:  Naz Jehangir; Caroline Yizhu Yu; Jeehey Song; Mohammad Ali Shariati; Steven Binder; Jill Beyer; Veronica Santini; Kathleen Poston; Yaping Joyce Liao
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

5.  The Retinal Posterior Pole in Early Parkinson's Disease: A Fundus Perimetry and SD-OCT Study.

Authors:  Massimo Cesareo; Ernesto Di Marco; Clarissa Giannini; Matteo Di Marino; Francesco Aiello; Antonio Pisani; Mariangela Pierantozzi; Nicola Biagio Mercuri; Carlo Nucci; Raffaele Mancino
Journal:  Clin Ophthalmol       Date:  2021-10-04

6.  Association of visual impairment with risk for future Parkinson's disease.

Authors:  Zhuoting Zhu; Wenyi Hu; Huan Liao; Zachary Tan; Yifan Chen; Danli Shi; Xianwen Shang; Xueli Zhang; Yu Huang; Honghua Yu; Wei Wang; Mingguang He; Xiaohong Yang
Journal:  EClinicalMedicine       Date:  2021-11-06

7.  Selectively reduced contrast sensitivity in high schizotypy.

Authors:  Lauren Harper; Emily Spencer; Colin Davidson; Claire V Hutchinson
Journal:  Exp Brain Res       Date:  2019-11-28       Impact factor: 1.972

8.  Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease.

Authors:  Ane Murueta-Goyena; Rocío Del Pino; Marta Galdós; Begoña Arana; Marian Acera; Mar Carmona-Abellán; Tamara Fernández-Valle; Beatriz Tijero; Olaia Lucas-Jiménez; Natalia Ojeda; Naroa Ibarretxe-Bilbao; Javier Peña; Jesus Cortes; Unai Ayala; Maitane Barrenechea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Ann Neurol       Date:  2020-11-09       Impact factor: 10.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.